Advanced liver organoids were able to secrete functional FVIII that could be used to stop bleeding in mice with hemophilia A, ...

Three months after transplanting the cells, the number of healthy cells had increased and were producing factor VIII in amounts sufficient to cure their hemophilia, the researchers found.

The hemophilia trial was typical of most early efforts at gene therapy. In this case, the disease is caused by a defect in a single gene, so providing cells with a new copy will correct the problem.

Researchers have created liver tissue that grows its own blood vessels, improving research into hemophilia and liver damage.

Transplanted cells can cure hemophilia A (the most common form of the disease) in an animal model, new research suggests. Researchers transplanted healthy liver endothelial cells from donor mice ...

Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic condition do not produce sufficient clotting factors, which can cause ...

A one-time, gene-based treatment for hemophilia increased the amount of a necessary blood clotting protein in men with a severe form of the disease.

A gene therapy using skin cells that are genetically modified to make clotting proteins, multiplied in a lab, and reinjected into a person eases some bleeding in patients with severe hemophilia.

Sonny is a 1-year-old Pitbull mix that Rucker got from a rescue and soon learned he has hemophilia, a rare blood disorder more often heard of in people. "I had no idea," Rucker said, "I had no idea." ...

Your blood contains proteins, called clotting factors, that help to control bleeding. Healthcare providers treat hemophilia by boosting clotting factor levels or replacing missing clotting factors.

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance induction, a study found.